Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2003
06/12/2003US20030109009 Using restriction enzymes; cloning; digestion
06/12/2003US20030109008 Cell proliferation, cell differentiation; stem cells
06/12/2003US20030109007 Process for producing N-acetylneuraminic acid
06/12/2003US20030109006 Isolation of lymphocytes, binding, forming culture product, cloning
06/12/2003US20030109005 Sequence determination; polymerase chain reactions
06/12/2003US20030109004 Culture product; cell transformation; genetic engineering using promoter
06/12/2003US20030109003 Antitumor agent; transformation of expression vector; genetic engineering; process control hybrids
06/12/2003US20030109001 Genetic engineering in prokaryotic cells; diagnosis of autoimmune disease using antibodies
06/12/2003US20030109000 Culture product; binding polypeptides containing activated end groups
06/12/2003US20030108999 Cell having amplified signal transduction pathway responses and uses therefor
06/12/2003US20030108998 Aggrecan degrading metallo proteases
06/12/2003US20030108993 Human mitochondrial chaperone protein
06/12/2003US20030108992 Identification of a novel domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function
06/12/2003US20030108990 Method for preparing deletion mutants
06/12/2003US20030108985 Structure for presenting desired peptide sequences
06/12/2003US20030108984 CD44 splice variant associated with rheumatoid arthritis
06/12/2003US20030108980 Bioluminescent methods for direct visual detection of environmental compounds
06/12/2003US20030108971 Enzyme
06/12/2003US20030108968 Determination lymphocytes to specific antigen in blood
06/12/2003US20030108967 Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP
06/12/2003US20030108965 Using polypeptide, detection of antibody; cancer of ovaries
06/12/2003US20030108963 Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer
06/12/2003US20030108961 Methods and compositions for diagnosing breast cancer
06/12/2003US20030108953 Truncated egf receptor
06/12/2003US20030108951 Screening drugs using antigens; suppress gene expression
06/12/2003US20030108948 Artificial antibody polypeptides
06/12/2003US20030108947 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
06/12/2003US20030108939 In vivo method for identifying target sites for antisense-mediated inhibition of a selected gene
06/12/2003US20030108937 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
06/12/2003US20030108933 Novel serine-threonine kinase-3
06/12/2003US20030108932 Ras guanine-nucleotide-exchange factor 1 (nrg1)
06/12/2003US20030108930 Method of evaluating drug efficacy and toxicity
06/12/2003US20030108928 MID 241 receptor, a novel G-protein coupled receptor
06/12/2003US20030108923 Blocking gene expression
06/12/2003US20030108917 Three-dimensional structure; surface sensitivity; analyzing genes
06/12/2003US20030108914 Amplification of nucleic acids
06/12/2003US20030108909 Genetic suppressor elements against human immunodeficiency virus
06/12/2003US20030108908 Hansenula polymorpha mutants and process for the preparation of recombinant proteins using the same
06/12/2003US20030108906 Signal transduction, gene expression of pain sequences; genetic engineering
06/12/2003US20030108904 Novel scavenger receptors
06/12/2003US20030108902 Generation of single-strand circular DNA from linear self-annealing segments
06/12/2003US20030108894 Novel polypeptide-atp-dependent helicase protein 68 and the polynucleotide encoding said polypeptide
06/12/2003US20030108889 Mutations; cloning; immunoglobulins; genetic engineering
06/12/2003US20030108887 Zinc finger proteins; genomes
06/12/2003US20030108886 Autogene nucleic acids encoding a secretable RNA polymerase
06/12/2003US20030108885 Methods and compositions for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs
06/12/2003US20030108883 Protein tyrosine phosphatase 1B (PTP1B); insulin resistance
06/12/2003US20030108882 Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid
06/12/2003US20030108880 Gene expression regulation
06/12/2003US20030108878 DNA chip and its preparation
06/12/2003US20030108877 Methods for selecting and producing selective pharmaceutical compounds and compositions using an established genetically altered cell-based library responsive to transcription factors; genetic constructs and library therefor.
06/12/2003US20030108874 Compositions and systems for identifying and comparing expressed genes (mRNAs) in eukaryotic organisms
06/12/2003US20030108873 Systems for the detection of target sequences
06/12/2003US20030108870 DNA amplification with a first primer having a random sequence of nucleotides at its 3'end and a generic sequence 5' of the random nucleotides, as well as a second primer with the generic sequence of the first primer
06/12/2003US20030108869 Leucine zipper domains of reporter molecule hydrolyze penicillin or cephalosporin substrates; gene expression
06/12/2003US20030108866 Peptide-nucleic acid (PNA) probes; amplification products; cervical scraping analysis/cancer diagnosis
06/12/2003US20030108865 Polymerase chain reactions; DNA electrophoresis
06/12/2003US20030108863 Nodavirus-like DNA expression vector and uses therefor
06/12/2003US20030108862 Genetic probes for hepatitis C virus (HCV) polymerase
06/12/2003US20030108858 Methods for the simultaneous detection of HCV antigens and HCV antibodies
06/12/2003US20030108642 Penicillium funiculosum strain useful for the production of enzymes
06/12/2003US20030108641 Improving rheological properties and quality of bread, alimentary paste products, noodles; strength and stability
06/12/2003US20030108570 Method and kit using recombinant proteins in fusion of porcine reproductive and respiratory syndrome virus and for diagnosis
06/12/2003US20030108569 Novel recombinant and mutant adenoviruses
06/12/2003US20030108562 Administering gag protein; vaccines for human immunodeficiency virus
06/12/2003US20030108559 Induction immunology response; cardiovascular disorders, anticholesterol agents
06/12/2003US20030108557 Biosynthesis; contacting plant cell with genetic engineered nucleic acid virus; gene expression of fusion protein; splitting using cyanogen bromide
06/12/2003US20030108554 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
06/12/2003US20030108550 Anti-procalcitonin antibodies and the preparation and use thereof
06/12/2003US20030108546 Apoptosis-inducing single-chain Fv
06/12/2003US20030108545 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
06/12/2003US20030108540 Inducing apoptosis in tissues; binding antibodies
06/12/2003US20030108538 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
06/12/2003US20030108532 Methods for identifying peptide aptamers capable of altering a cell phenotype
06/12/2003US20030108531 Genes for transfection into bony tissues
06/12/2003US20030108530 Antisense inhibiting melanoma invasion and functional analogs thereof
06/12/2003US20030108526 Gene expression marking
06/12/2003US20030108525 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
06/12/2003US20030108522 Method for using Smad for gene therapy of solid malignant tumors
06/12/2003US20030108521 Adenovirus protein IX, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
06/12/2003US20030108518 TRX1 antibody and uses therefor
06/12/2003US20030108517 Membrane-bound cytokine compositions and methods of modulating an immune response using same
06/12/2003CA2847885A1 Transgenic animals bearing human ig.lambda. light chain genes
06/12/2003CA2470508A1 Library screening
06/12/2003CA2469671A1 A process for the preparation of a non-toxic anthrax vaccine
06/12/2003CA2469477A1 Phenotypic screen of chimeric proteins
06/12/2003CA2469403A1 Protein arrays for allelic variants and uses thereof
06/12/2003CA2469356A1 Nuclear protein "shoca" - a component of the wnt signalling pathway
06/12/2003CA2469066A1 Labelled nucleotides
06/12/2003CA2468991A1 Methods and reagents for diagnosis and treatment of diabetes
06/12/2003CA2468961A1 Method for the identification of genetic features for complex genetics classifiers
06/12/2003CA2468944A1 Migration of hematopoietic stem cells and progenitor cells to the liver
06/12/2003CA2468907A1 Effectors of innate immunity
06/12/2003CA2468853A1 Prenyltransferase from plants
06/12/2003CA2468851A1 Gips, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
06/12/2003CA2468743A1 Direct write nanolithographic deposition of nucleic acids from nanoscopic tips
06/12/2003CA2468739A1 Suppression of polymeric alleles
06/12/2003CA2468727A1 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters
06/12/2003CA2468713A1 Multiplex real-time quantitative pcr
06/12/2003CA2468710A1 Chromosomal saturation mutagenesis
1 ... 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 ... 4023